Walter Miller
Financieel Directeur/CFO bij HEIDELBERG PHARMA AG
Oorsprong van het eerstegraads netwerk van Walter Miller
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Miscellaneous Commercial Services | 5 | |
Nuvisan Oncology SA
 Nuvisan Oncology SA Miscellaneous Commercial ServicesCommercial Services Nuvisan Oncology SA is a French company that was founded in 1996. The private company is based in Paris, France. Nuvisan Oncology engages in research and development of physical and natural science.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Walter Miller via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| dievini Verwaltungs GmbH | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer Chief Executive Officer | ||
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
J.F. Müller & Sohn AG
 J.F. Müller & Sohn AG Forest ProductsNon-Energy Minerals J.F. Müller & Sohn AG manufactures hardwood veneer, softwood veneer, and plywood. The company was founded by Friedrich Jacob Müller in 1795 and is headquartered in Hamburg, Germany. | Forest Products | Chairman Chairman | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| University of Mannheim | College/University | Doctorate Degree Undergraduate Degree | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Corporate Officer/Principal Doctorate Degree | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Nuvisan GmbH
 Nuvisan GmbH BiotechnologyHealth Technology Nuvisan GmbH operates as an independent research institute. It performs legally prescribed drug studies and specializes in bioanalytical analysis, pharmaceutical analysis, quality control, stability testing and test sample production, as well as clinical drug development. The company was founded in 1979 and is headquartered in Neu-Ulm, Germany. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Febit, Inc. | Director/Board Member Chairman | ||
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chairman | |
W. Söhngen GmbH
 W. Söhngen GmbH Medical SpecialtiesHealth Technology W. Söhngen GmbH engages in the development, production, and distribution of medical kits. It offers products for wound care as well as first aid and emergency medicine. The company is headquartered in Taunusstein, Germany. | Medical Specialties | Chief Executive Officer | |
Trommsdorff GmbH & Co. KG
 Trommsdorff GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Trommsdorff GmbH & Co. KG engages in the manufacture, development, and distribution of pharmaceuticals, as well as nutritional and dietary supplements. It also sells medical equipment and devices. The company is headquartered in Alsdorf, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| Fachhochschule Düsseldorf | College/University | Corporate Officer/Principal | |
| Humboldt-Universität zu Berlin | College/University | Undergraduate Degree | |
| Technical University of Berlin | College/University | Corporate Officer/Principal | |
Salvator Vermögensverwaltungs GmbH
 Salvator Vermögensverwaltungs GmbH Real Estate DevelopmentFinance Salvator Vermögensverwaltungs GmbH is a real estate investment company based in Munich, Germany. The company has been investing in the greater German area since 1996, mostly in other German-speaking regions, mostly in residential properties, and sells them again in detail. In addition to this core business, the company is now also involved in the area of corporate participations. The currently drawn capital of society is €1 million. Susanne Klimek has been the CEO of the company since 1996. | Real Estate Development | Chief Executive Officer | |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOPRO Baden-Württemberg GmbH
 BIOPRO Baden-Württemberg GmbH Miscellaneous Commercial ServicesCommercial Services BIOPRO Baden-Württemberg GmbH provides business support services to research institutions. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| EBEWE Arzneimittel GmbH | Chief Executive Officer | ||
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| PROTEOME SCIENCES PLC | Medical Specialties | Chief Executive Officer | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BASF SE | Electrical Products | Corporate Officer/Principal | |
| Bootcamp | Founder | ||
Nuvisan ICB GmbH
 Nuvisan ICB GmbH Miscellaneous Commercial ServicesCommercial Services Nuvisan ICB GmbH is a clinical research organization based in Berlin, Germany. Nuvisan ICB specializes in clinical research and offers opportunities for individuals to participate in studies. The German company's focus is on providing valuable results for their clients and participants. The private company was founded in 2020 and is led by CEOs Dietrich Bruchmann, Arnoud Huisman, and Hans Lindner. | Miscellaneous Commercial Services | Chief Executive Officer | |
Convert Pharmaceuticals SA
 Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Indiana University | College/University | Doctorate Degree | |
| University of Pecs | College/University | Doctorate Degree | |
| Long Island University | College/University | Graduate Degree |
Statistieken
Internationaal
| Duitsland | 40 |
| Verenigde Staten | 6 |
| Zwitserland | 2 |
| Japan | 2 |
| Australië | 2 |
Sectoraal
| Health Technology | 21 |
| Commercial Services | 10 |
| Consumer Services | 9 |
| Finance | 5 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 66 |
| Chief Executive Officer | 41 |
| Chairman | 34 |
| Corporate Officer/Principal | 27 |
| Chief Tech/Sci/R&D Officer | 13 |
Sterkste connecties
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Mathias Hothum | 19 |
| Mariola Söhngen | 12 |
| Birgit Kudlek | 11 |
| Ignacio Faus | 9 |
| Andreas Pahl | 9 |
| Jan Schmidt-Brand | 9 |
| Georg F. Baur | 8 |
| Matthias Baumann | 7 |
| Dong Zhou Liu | 5 |
| Dietrich Bruchmann | 3 |
| Susanne Klimek | 2 |
| Antal Hajos | 2 |
| Michael Schultz | 2 |
- Beurs
- Insiders
- Walter Miller
- Bedrijfsconnecties
